CompletedEarly Phase 1

Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

United States53 participantsStarted 2018-02-01

Plain-language summary

This is a study comparing the effects of Delta-9-Tetrahydrocannabinol (THC) versus Cannabidiol (CBD) versus a placebo on chronic non-cancer pain.

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Age between 18-50 yrs.
✓. History of cannabis use.
✓. Chronic musculoskeletal and joint pain for at least 3 months or longer.
✓. Participants must live within a 60 mile radius of Salt Lake City, Utah to be eligible.

Brain Changes

Timeframe: 5 days

NCT IDNCT03215940

SponsorUniversity of Utah

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-01